TMPRSS2 is a functional receptor for human coronavirus HKU1

Nell Saunders1, Ignacio Fernandez2, Cyril Planchais3

  • 1Virus & Immunity Unit, Institut Pasteur, Université de Paris Cité, CNRS UMR 3569, Paris, France.

Nature
|October 25, 2023
PubMed

Insights

Transmembrane serine protease 2 (TMPRSS2) acts as a direct receptor for the HKU1 coronavirus, facilitating cell entry and infection. This discovery reveals a novel viral binding strategy and potential therapeutic target for common cold coronaviruses.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Four endemic human coronaviruses (HKU1, 229E, NL63, OC43) cause common colds globally.
  • Coronavirus entry relies on spike protein priming by cellular proteases like TMPRSS2 or cathepsins.
  • Receptors for HKU1 and OC43 spikes remain unidentified, unlike NL63 (ACE2) and 229E (hAPN).

Purpose of the Study:

  • To identify the cellular receptor for the HKU1 coronavirus.
  • To elucidate the mechanism of HKU1 entry and potential therapeutic interventions.

Main Methods:

  • Investigated TMPRSS2 as a functional receptor for HKU1.
  • Assessed HKU1 spike-mediated cell-cell fusion and pseudovirus infection.
  • Utilized catalytically inactive TMPRSS2 mutants and anti-TMPRSS2 nanobodies.
  • Performed binding affinity studies and tested inhibition of authentic HKU1 virus infection.

Main Results:

  • TMPRSS2 directly binds to the HKU1 spike protein, acting as a functional receptor.
  • TMPRSS2 triggers HKU1 spike-mediated cell-cell fusion and pseudovirus infection.
  • Anti-TMPRSS2 nanobodies effectively inhibit HKU1 attachment, fusion, and infection in cell cultures and primary bronchial cells.

Conclusions:

  • TMPRSS2 serves as a direct receptor for HKU1, distinct from its role in priming other coronaviruses.
  • This finding highlights diverse coronavirus evolutionary strategies for cell binding and entry.
  • Targeting TMPRSS2 with nanobodies presents a promising therapeutic strategy against HKU1 infections.